---
figid: PMC4023047__fphar-05-00103-g0003
figtitle: Role of POR in biosynthesis of androgens in classic and alternate pathways
organisms:
- Homo sapiens
- Mus musculus
- Bacillus subtilis
- Plasmodium yoelii
- Metatheria
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC4023047
filename: fphar-05-00103-g0003.jpg
figlink: /pmc/articles/PMC4023047/figure/F3/
number: F3
caption: 'Role of POR in biosynthesis of androgens in classic and alternate pathways.
  The classic pathway proceeds from transfer cholesterol to mitochondrion through
  steroidogenic acute regulatory protein (StAR). In the mitochondrion cholesterol
  is converted to pregnenolone by CYP11A1. The biosynthesis process then continues
  from pregnenolone to 17OHPreg and DHEA to androstenedione or androstenediol and
  then to testosterone in testicular Leydig cells. Testosterone (T) is converted to
  dihydrotesterone (DHT) in genital skin. The backdoor pathway proceeds from 17OHPreg
  to 17OHProg, 17OH-DHP, 17OH-Allo, androsterone, androstanediol (A''diol) and then
  to DHT in the testis. Abbreviations: CYP11A1, P450scc, cholesterol side-chain cleavage
  enzyme; StAR, steroidogenic acute regulatory protein; FDX1, Adrenodoxin; FDXR, NADPH
  adrenodoxin oxidoreductase; CYP17A1, P450c17, 17α-hydroxylase/17,20-lyase; HSD3B2,
  3β HSD2, 3β-hydroxysteroid dehydrogenase, type 2; CYB5, cytochrome b5; POR, P450
  oxidoreductase; HSD17B3, 17β HSD3, 17β-hydroxysteroid dehydrogenase, type 3; and
  SRD5A2, 5α-reductase, type 2. The alternative pathway has four additional enzymes:
  SRD5A1, 5α-reductase, type 1; AKR1C2, Aldo-keto reductase 1C2, 3αHSD3; and AKR1C4,
  Aldo-keto reductase 1C4, 3αHSD1, for reductive 3αHSD activity; and HSD17B6, 17β
  HSD6, 17β-hydroxysteroid dehydrogenase, type 6; and/or AKR1C2/4 for oxidative 3αHSD
  activity. Full steroid names: 17OHPreg, 17-hydroxypregnenolone; 17OHProg, 17-hydroxyprogesterone;
  17OH-DHP, 17-hydroxydihydroprogesterone (5α-pregnan-3α,17α-ol-20-one); 17OH-Allo,
  17-hydroxyallopregnanolone (5α-pregnan-3α,17α-diol-20-one; P''diol); A''diol, androstanediol;
  T, testosterone; DHT, dihydrotestosterone, DHEA, dehydroepiandrosterone.'
papertitle: Pharmacogenomics of human P450 oxidoreductase.
reftext: Amit V. Pandey, et al. Front Pharmacol. 2014;5:103.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9475607
figid_alias: PMC4023047__F3
figtype: Figure
redirect_from: /figures/PMC4023047__F3
ndex: 1a574770-deac-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4023047__fphar-05-00103-g0003.html
  '@type': Dataset
  description: 'Role of POR in biosynthesis of androgens in classic and alternate
    pathways. The classic pathway proceeds from transfer cholesterol to mitochondrion
    through steroidogenic acute regulatory protein (StAR). In the mitochondrion cholesterol
    is converted to pregnenolone by CYP11A1. The biosynthesis process then continues
    from pregnenolone to 17OHPreg and DHEA to androstenedione or androstenediol and
    then to testosterone in testicular Leydig cells. Testosterone (T) is converted
    to dihydrotesterone (DHT) in genital skin. The backdoor pathway proceeds from
    17OHPreg to 17OHProg, 17OH-DHP, 17OH-Allo, androsterone, androstanediol (A''diol)
    and then to DHT in the testis. Abbreviations: CYP11A1, P450scc, cholesterol side-chain
    cleavage enzyme; StAR, steroidogenic acute regulatory protein; FDX1, Adrenodoxin;
    FDXR, NADPH adrenodoxin oxidoreductase; CYP17A1, P450c17, 17α-hydroxylase/17,20-lyase;
    HSD3B2, 3β HSD2, 3β-hydroxysteroid dehydrogenase, type 2; CYB5, cytochrome b5;
    POR, P450 oxidoreductase; HSD17B3, 17β HSD3, 17β-hydroxysteroid dehydrogenase,
    type 3; and SRD5A2, 5α-reductase, type 2. The alternative pathway has four additional
    enzymes: SRD5A1, 5α-reductase, type 1; AKR1C2, Aldo-keto reductase 1C2, 3αHSD3;
    and AKR1C4, Aldo-keto reductase 1C4, 3αHSD1, for reductive 3αHSD activity; and
    HSD17B6, 17β HSD6, 17β-hydroxysteroid dehydrogenase, type 6; and/or AKR1C2/4 for
    oxidative 3αHSD activity. Full steroid names: 17OHPreg, 17-hydroxypregnenolone;
    17OHProg, 17-hydroxyprogesterone; 17OH-DHP, 17-hydroxydihydroprogesterone (5α-pregnan-3α,17α-ol-20-one);
    17OH-Allo, 17-hydroxyallopregnanolone (5α-pregnan-3α,17α-diol-20-one; P''diol);
    A''diol, androstanediol; T, testosterone; DHT, dihydrotestosterone, DHEA, dehydroepiandrosterone.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP17A1
  - POR
  - VDAC2
  - STAR
  - GUCY2C
  - CD163L1
  - CYP11A1
  - FDXR
  - FDX1
  - SRD5A1
  - AKR1C2
  - HSD3B2
  - HSD17B3
  - RNU1-4
  - CYB5A
  - HSD17B6
  - SRD5A2
  - Cyp17a1
  - Por
  - Arfip2
  - Star
  - Cyp11a1
  - Fdxr
  - Fdx1
  - Srd5a1
  - Hsd3b2
  - Hsd17b3
  - Cyb5a
  - Hsd17b6
  - Srd5a2
  - cyp17a1
  - pora
  - star
  - cyp11a1.1
  - fdxr
  - fdx1
  - srd5a1
  - hsd3b2
  - hsd17b3
  - cyb5a
  - Androstenedione
  - Androsterone
  - Cholesterol
  - DHEA
  - Pregnenolone
  - Dihydrotestosterone
  - Testosterone
---
